Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation

被引:49
作者
Gao, Ping [1 ]
Wang, Zhidong [2 ]
Hu, Zhanliang [2 ]
Jiao, Xuan [3 ]
Yao, Yue [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin 150086, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin 150086, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Harbin, Peoples R China
基金
中国博士后科学基金;
关键词
BRD4; circ_0074027; circRNA; MADD; miR-185-3p; NSCLC; LUNG-CANCER; LONG; EVOLUTION; BRD4; MADD;
D O I
10.1002/jcb.29484
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs play an imperative role in cancer development and metastasis by regulating oncogenic and tumor-suppressive pathways. However, the role and mechanism of circ_0074027 in non-small-cell lung cancer (NSCLC) have not been elucidated. The expression levels of circ_0074027 were detected by qRT-PCR. The link between circ_0074027 expression and clinicopathologic parameters was analyzed by Fisher's exact test. The prognostic role of circ_0074027 was investigated by Kaplan-Meier and Cox regression analysis. Cell counting kit-8 and flow cytometric assays were utilized to evaluate NSCLC cell proliferation and apoptosis, respectively. Wound scratch and Transwell tests were applied to detect cell migratory and invasive capacities. The interaction potential of circ_0074027 and miR-185-3p was analyzed by the circBank database, and verified by dual-luciferase reporter assay. The downstream gene of miR-185-3p was also investigated. Circ_0074027 was elevated in NSCLC specimens and cell lines. Overexpressed circ_0074027 was related to more advanced TNM stages, poorer differentiation grade, and worse overall survival. Upregulated circ_0074027 increased the proliferation of H1299 cells by inhibiting cell apoptosis. Cell migration and invasion were enhanced after circ_0074027 overexpression. Silenced circ_0074027 caused the opposite effects in the A549 cell line. For mechanism investigation, circ_0074027 directly sponges miR-185-3p to enhance bromodomain-containing protein 4 (BRD4) and MAPK-activating death domain-containing protein (MADD) expression levels at the posttranscriptional level. Furthermore, we found the oncogenic function of circ_0074027 is attributed to its modulation of BRD4 and MADD. Collectively, upregulated circ_0074027 in NSCLC accelerates cell progression via miR-185-3p/BRD4/MADD pathway as a competing endogenous RNA.
引用
收藏
页码:2632 / 2642
页数:11
相关论文
共 29 条
  • [1] Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
    Abbosh, Christopher
    Birkbak, Nicolai J.
    Wilson, Gareth A.
    Jamal-Hanjani, Mariam
    Constantin, Tudor
    Salari, Raheleh
    Le Quesne, John
    Moore, David A.
    Veeriah, Selvaraju
    Rosenthal, Rachel
    Marafioti, Teresa
    Kirkizlar, Eser
    Watkins, Thomas B. K.
    McGranahan, Nicholas
    Ward, Sophia
    Martinson, Luke
    Riley, Joan
    Fraioli, Francesco
    Al Bakir, Maise
    Gronroos, Eva
    Zambrana, Francisco
    Endozo, Raymondo
    Bi, Wenya Linda
    Fennessy, Fiona M.
    Sponer, Nicole
    Johnson, Diana
    Laycock, Joanne
    Shafi, Seema
    Czyzewska-Khan, Justyna
    Rowan, Andrew
    Chambers, Tim
    Matthews, Nik
    Turajlic, Samra
    Hiley, Crispin
    Lee, Siow Ming
    Forster, Martin D.
    Ahmad, Tanya
    Falzon, Mary
    Borg, Elaine
    Lawrence, David
    Hayward, Martin
    Kolvekar, Shyam
    Panagiotopoulos, Nikolaos
    Janes, Sam M.
    Thakrar, Ricky
    Ahmed, Asia
    Blackhall, Fiona
    Summers, Yvonne
    Hafez, Dina
    Naik, Ashwini
    [J]. NATURE, 2017, 545 (7655) : 446 - +
  • [2] Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor α-induced apoptosis and activation of caspase-8 and-3
    Al-Zoubi, AM
    Efimova, EV
    Kaithamana, S
    Martinez, O
    El-Idrissi, MEA
    Dogan, RE
    Prabhakar, BS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47202 - 47211
  • [3] BET domain co-regulators in obesity, inflammation and cancer
    Belkina, Anna C.
    Denis, Gerald V.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (07) : 465 - 477
  • [4] First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
    Carbone, D. P.
    Reck, M.
    Paz-Ares, L.
    Creelan, B.
    Horn, L.
    Steins, M.
    Felip, E.
    van den Heuvel, M. M.
    Ciuleanu, T. -E.
    Badin, F.
    Ready, N.
    Hiltermann, T. J. N.
    Nair, S.
    Juergens, R.
    Peters, S.
    Minenza, E.
    Wrangle, J. M.
    Rodriguez-Abreu, D.
    Borghaei, H.
    Blumenschein, G. R.
    Villaruz, L. C.
    Havel, L.
    Krejci, J.
    Corral Jaime, J.
    Chang, H.
    Geese, W. J.
    Bhagavatheeswaran, P.
    Chen, A. C.
    Socinski, M. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) : 2415 - 2426
  • [5] Chiang C.M., 2009, Biol Rep, V1, P98
  • [6] Neural circular transcriptomes across mammalian species
    Curry-Hyde, Ashton
    Ueberham, Uwe
    Arendt, Thomas
    Janitz, Michael
    [J]. GENOMICS, 2020, 112 (02) : 1162 - 1166
  • [7] Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression
    Gao, Zhongyuan
    Yuan, Ting
    Zhou, Xiao
    Ni, Ping
    Sun, Geng
    Li, Ping
    Cheng, Zhixiang
    Wang, Xuerong
    [J]. CANCER BIOLOGY & THERAPY, 2018, 19 (05) : 407 - 415
  • [8] Tracking the Evolution of Non-Small-Cell Lung Cancer
    Jamal-Hanjani, M.
    Wilson, G. A.
    McGranahan, N.
    Birkbak, N. J.
    Watkins, T. B. K.
    Veeriah, S.
    Shafi, S.
    Johnson, D. H.
    Mitter, R.
    Rosenthal, R.
    Salm, M.
    Horswell, S.
    Escudero, M.
    Matthews, N.
    Rowan, A.
    Chambers, T.
    Moore, D. A.
    Turajlic, S.
    Xu, H.
    Lee, S. -M.
    Forster, M. D.
    Ahmad, T.
    Hiley, C. T.
    Abbosh, C.
    Falzon, M.
    Borg, E.
    Marafioti, T.
    Lawrence, D.
    Hayward, M.
    Kolvekar, S.
    Panagiotopoulos, N.
    Janes, S. M.
    Thakrar, R.
    Ahmed, A.
    Blackhall, F.
    Summers, Y.
    Shah, R.
    Joseph, L.
    Quinn, A. M.
    Crosbie, P. A.
    Naidu, B.
    Middleton, G.
    Langman, G.
    Trotter, S.
    Nicolson, M.
    Remmen, H.
    Kerr, K.
    Chetty, M.
    Gomersall, L.
    Fennell, D. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (22) : 2109 - 2121
  • [9] A functional variant in GREM1 confers risk for colorectal cancer by disrupting a hsa-miR-185-3p binding site
    Li, Jiaoyuan
    Liu, Hui
    Zou, Li
    Ke, Juntao
    Zhang, Yi
    Zhu, Ying
    Yang, Yang
    Gong, Yajie
    Tian, Jianbo
    Zou, Danyi
    Peng, Xiating
    Gong, Jing
    Zhong, Rong
    Huang, Kun
    Chang, Jiang
    Miao, Xiaoping
    [J]. ONCOTARGET, 2017, 8 (37) : 61318 - 61326
  • [10] miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro
    Liu, Chao
    Li, Guo
    Ren, Shuling
    Su, Zhongwu
    Wang, Yunyun
    Tian, Yongquan
    Liu, Yong
    Qiu, Yuanzheng
    [J]. ONCOLOGY LETTERS, 2017, 13 (04) : 2631 - 2636